What's the main difference between PFE and MRK?

PFE is a high-yield stock from Pfizer; MRK is a dividend-growth stock from Merck. Two big pharma dividend payers — a high-yield reset story versus a steadier dividend grower.

Does PFE or MRK pay more dividends?

As of Jul 10, 2026, PFE yields about 7.09% and MRK about 2.72%, so PFE currently pays the higher yield. PFE pays quarterly; MRK pays quarterly. Yields move daily, so verify current figures and use the calculators below to model the income yourself. Higher-yield funds pay more today, while dividend-growth funds start lower and raise the payout over time.

Which is better, PFE or MRK?

Neither is universally better — they suit different goals. PFE fits an investor who wants a high current yield from a single company, with limited dividend growth; MRK fits one who wants income from this strategy. Match the fund to your objective, time horizon, and tax situation, and consider a licensed advisor.

Can I hold both PFE and MRK?

Many investors do, to blend current income with growth. Just be aware of overlap — if both hold similar large-cap US stocks, you may be less diversified than the two tickers suggest.

PFE vs MRK

Two big pharma dividend payers — a high-yield reset story versus a steadier dividend grower. Here’s how PFE and MRK compare for dividend investors — with a calculator for each so you can model the income yourself.

PFE

Pfizer Inc.

Type: High-yield stock
Issuer: Pfizer
Pays: quarterly

Pfizer is one of the largest global pharmaceutical companies, with a broad portfolio of vaccines and branded medicines. It pays a quarterly dividend that, after the run-down of pandemic-era revenue, has carried a notably high yield relative to its large-cap peers.

PFE dividend calculator

MRK

Merck & Co., Inc.

Type: Dividend-growth stock
Issuer: Merck
Pays: quarterly

Merck is a major global pharmaceutical company known for vaccines, oncology, and animal-health products. It pays a quarterly dividend and has a multi-year record of annual increases.

MRK dividend calculator

PFE vs MRK dividend, side by side

Current dividend figures for PFE and MRK as of Jul 10, 2026. Yields and payouts change — verify the latest numbers with your broker before investing.

Dividend comparison

PFE versus MRK: dividend yield, annual dividend, payout frequency, latest payment, and ex-dividend date.
Metric	PFE	MRK
Dividend yield	~7.09%	~2.72%
Annual dividend / share (TTM)	$1.72	$3.36
Payout frequency	Quarterly	Quarterly
Latest dividend / share	$0.43	$0.85
Latest ex-dividend date	May 8, 2026	Jun 15, 2026

As of Jul 10, 2026, PFE carries the higher current yield — roughly 7.09% versus MRK’s 2.72%. Both pay on a quarterly schedule. Keep in mind that PFE’s higher yield typically comes with limited price growth or higher risk — a larger headline number is not automatically the better investment.

Per-share dividends are not directly comparable between funds that trade at different share prices — yield is the like-for-like measure. Source: dividend records via PFE, MRK. Not financial advice.

How PFE and MRK differ

PFE — Pfizer is one of the largest global pharmaceutical companies, with a broad portfolio of vaccines and branded medicines. It pays a quarterly dividend that, after the run-down of pandemic-era revenue, has carried a notably high yield relative to its large-cap peers.

MRK — Merck is a major global pharmaceutical company known for vaccines, oncology, and animal-health products. It pays a quarterly dividend and has a multi-year record of annual increases.

In practice the choice comes down to your goal. PFE suits an investor who wants a high current yield from a single company, with limited dividend growth, while MRK suits one who wants income from this strategy. The two are not mutually exclusive — plenty of portfolios hold a growth-oriented fund and an income-oriented one together. What matters is matching each to its job and not judging a fund on its headline yield alone.

Rather than compare a single snapshot yield (which moves daily), open each calculator and enter current figures: the PFE calculator and the MRK calculator. To compare long-term compounding head to head, run the same contributions through the dividend reinvestment calculator with each fund’s assumptions.

Educational comparison only — not a recommendation to buy or sell either fund. Yields and strategies change; verify current figures and consider a licensed advisor.

PFE vs MRK FAQ

What's the main difference between PFE and MRK?: PFE is a high-yield stock from Pfizer; MRK is a dividend-growth stock from Merck. Two big pharma dividend payers — a high-yield reset story versus a steadier dividend grower.
Does PFE or MRK pay more dividends?: As of Jul 10, 2026, PFE yields about 7.09% and MRK about 2.72%, so PFE currently pays the higher yield. PFE pays quarterly; MRK pays quarterly. Yields move daily, so verify current figures and use the calculators below to model the income yourself. Higher-yield funds pay more today, while dividend-growth funds start lower and raise the payout over time.
Which is better, PFE or MRK?: Neither is universally better — they suit different goals. PFE fits an investor who wants a high current yield from a single company, with limited dividend growth; MRK fits one who wants income from this strategy. Match the fund to your objective, time horizon, and tax situation, and consider a licensed advisor.
Can I hold both PFE and MRK?: Many investors do, to blend current income with growth. Just be aware of overlap — if both hold similar large-cap US stocks, you may be less diversified than the two tickers suggest.

See all dividend ETF comparisons →